Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Real-Time Price · USD
39.14
+0.22 (0.57%)
Jun 3, 2026, 4:00 PM EDT - Market closed
GRDN Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,456 | 1,449 | 1,228 | 1,046 | 908.91 | 792.07 | |
Revenue Growth (YoY) | 13.54% | 17.93% | 17.42% | 15.10% | 14.75% | 7.63% |
Cost of Revenue | 1,151 | 1,156 | 984.04 | 837.88 | 723.04 | 630.81 |
Gross Profit | 304.68 | 292.72 | 244.37 | 208.31 | 185.87 | 161.27 |
Selling, General & Admin | 227.31 | 220.02 | 307.29 | 167.36 | 133.88 | 118.09 |
Other Operating Expenses | - | - | - | - | - | 13.03 |
Total Operating Expenses | 227.31 | 220.02 | 307.29 | 167.36 | 133.88 | 131.12 |
Operating Income | 77.37 | 72.7 | -62.92 | 40.95 | 51.99 | 30.15 |
Interest Expense | -0.65 | -0.67 | -3.28 | -2.86 | -1.93 | -1.64 |
Other Non-Operating Income (Expense) | 1.89 | 1.39 | -0.28 | -0.37 | -0.4 | -0.19 |
Total Non-Operating Income (Expense) | 1.24 | 0.72 | -3.56 | -3.23 | -2.33 | -1.82 |
Pretax Income | 78.61 | 73.42 | -66.48 | 37.72 | 49.66 | 28.33 |
Provision for Income Taxes | 25.38 | 24.47 | 4.56 | - | - | - |
Net Income | 53.07 | 49.22 | -110.05 | 0 | 35.42 | 16.31 |
Minority Interest in Earnings | 0.16 | -0.26 | 39.01 | 37.72 | -14.24 | -12.01 |
Net Income to Common | 53.07 | 49.22 | -110.05 | 0 | 35.42 | 16.31 |
Net Income Growth | - | - | - | - | 117.12% | -18.20% |
Shares Outstanding (Basic) | 63 | 62 | 62 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 63 | 63 | 62 | 0 | 0 | 0 |
Shares Change (YoY) | 0.32% | 2.08% | 62005700.00% | - | - | - |
EPS (Basic) | 0.85 | 0.79 | -1.77 | - | 354210.00 | 163140.00 |
EPS (Diluted) | 0.83 | 0.78 | -1.77 | - | 354210.00 | 163140.00 |
EPS Growth | - | - | - | - | 117.12% | - |
Shares Outstanding | 63.32 | 63.32 | 63.29 | 0 | 0 | 0 |
Free Cash Flow | 70.01 | 80.71 | 41.59 | 56.26 | 31.75 | 49.22 |
Free Cash Flow Growth | -13.26% | 94.05% | -26.08% | 77.20% | -35.48% | 11.17% |
Free Cash Flow Per Share | 1.10 | 1.28 | 0.67 | 562630.00 | 317520.00 | 492160.00 |
Gross Margin | 20.93% | 20.21% | 19.89% | 19.91% | 20.45% | 20.36% |
Operating Margin | 5.31% | 5.02% | -5.12% | 3.91% | 5.72% | 3.81% |
Profit Margin | 3.66% | 3.38% | -5.78% | 3.61% | 5.46% | 3.58% |
FCF Margin | 4.81% | 5.57% | 3.39% | 5.38% | 3.49% | 6.21% |
EBITDA | 94.67 | 95.04 | -43.15 | 59.18 | 68.55 | 46.68 |
EBITDA Margin | 6.50% | 6.56% | -3.51% | 5.66% | 7.54% | 5.89% |
EBIT | 77.37 | 72.7 | -62.92 | 40.95 | 51.99 | 30.15 |
EBIT Margin | 5.31% | 5.02% | -5.12% | 3.91% | 5.72% | 3.81% |
Effective Tax Rate | 32.29% | 33.32% | -6.85% | 0.00% | 0.00% | 0.00% |